stella
beta
Nab-TPC vs GP Combined With Camrelizumab in the Treatment of Recurrent/Metastatic Nasopharyngeal Carcinoma — Stella
Recruiting
Back to Nasopharyngeal Cancinoma (NPC) trials
Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations
(1 site)
China
SunYat-senU, Guangzhou, Guangdong
View full record on ClinicalTrials.gov